{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:46:13Z","timestamp":1790340373374,"version":"4.1.0"},"reference-count":156,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00459","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T03:15:51Z","timestamp":1476846951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":103,"title":["Alzheimer Disease: Crosstalk between the Canonical Wnt\/Beta-Catenin Pathway and PPARs Alpha and Gamma"],"prefix":"10.3389","volume":"10","author":[{"given":"Alexandre","family":"Vall\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Lecarpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nurt.2008.08.002","article-title":"ALS drug development: reflections from the past and a way forward","volume":"5","author":"Aggarwal","year":"2008","journal-title":"Neurotherapeutics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jnr.10737","article-title":"ADAMs family members as amyloid precursor protein alpha-secretases","volume":"74","author":"Allinson","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yexcr.2004.02.028","article-title":"Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons","volume":"297","author":"Alvarez","year":"2004","journal-title":"Exp. Cell Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrm2717","article-title":"Proximal events in Wnt signal transduction","volume":"10","author":"Angers","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.chembiol.2010.08.012","article-title":"Chemical-genetic screen identifies riluzole as an enhancer of Wnt\/beta-catenin signaling in melanoma","volume":"17","author":"Biechele","year":"2010","journal-title":"Chem. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.arr.2008.11.003","article-title":"Wnt signaling in Alzheimer's disease: up or down, that is the question","volume":"8","author":"Boonen","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1042\/BST0380967","article-title":"From tau phosphorylation to tau aggregation: what about neuronal death?","volume":"38","author":"Bu\u00e9e","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"B10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"B11","doi-asserted-by":"publisher","first-page":"10908","DOI":"10.1523\/JNEUROSCI.3987-04.2004","article-title":"Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide","volume":"24","author":"Camacho","year":"2004","journal-title":"J. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","article-title":"Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain","volume":"24","author":"Caricasole","year":"2004","journal-title":"J. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1471-4159.2006.03867.x","article-title":"Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells","volume":"98","author":"Caruso","year":"2006","journal-title":"J. Neurochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1326-5-3","article-title":"Wnt-5a occludes Abeta oligomer-induced depression of glutamatergic transmission in hippocampal neurons","volume":"5","author":"Cerpa","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"B15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1471-4159.2004.02535.x","article-title":"Arachidonic acid increases choline acetyltransferase activity in spinal cord neurons through a protein kinase C-mediated mechanism","volume":"90","author":"Chalimoniuk","year":"2004","journal-title":"J. Neurochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1083\/jcb.200309096","article-title":"A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules","volume":"164","author":"Ciani","year":"2004","journal-title":"J. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1042\/BJ20050560","article-title":"Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death","volume":"391","author":"D'Abramo","year":"2005","journal-title":"Biochem. J."},{"key":"B20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03402076","article-title":"[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients","volume":"8","author":"Colciaghi","year":"2002","journal-title":"Mol. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/01.WNL.0000106953.49802.9C","article-title":"Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease","volume":"62","author":"Colciaghi","year":"2004","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.1073\/pnas.1504890112","article-title":"Activation of peroxisome proliferator-activated receptor alpha stimulates ADAM10-mediated proteolysis of APP","volume":"112","author":"Corbett","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1871527312666131223113900","article-title":"Wnt\/\u03b2-catenin signaling in Alzheimer's disease","volume":"13","author":"De Ferrari","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1073\/pnas.0603523104","article-title":"Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease","volume":"104","author":"De Ferrari","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2006-9209","article-title":"Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease","volume":"9","author":"de la Monte","year":"2006","journal-title":"J. Alzheimers. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1210\/er.20.5.649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cvr\/cvp183","article-title":"A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy","volume":"84","author":"Djouadi","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","article-title":"Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease","volume":"67","author":"Donahue","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1006\/bbrc.1996.1044","article-title":"Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2","volume":"224","author":"Elbrecht","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1093\/brain\/awq217","article-title":"Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease","volume":"133","author":"Epis","year":"2010","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","article-title":"Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology","volume":"35","author":"Escribano","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nbd.2004.07.016","article-title":"M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway","volume":"17","author":"Far\u00edas","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.nbd.2004.09.012","article-title":"The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components","volume":"18","author":"Far\u00edas","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e14382","DOI":"10.1371\/journal.pone.0014382","article-title":"Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice","volume":"5","author":"Fiorentini","year":"2010","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.expneurol.2009.09.014","article-title":"Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease","volume":"223","author":"Folwell","year":"2010","journal-title":"Exp. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.brainresrev.2004.07.018","article-title":"Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease","volume":"47","author":"Fuentealba","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1600-0501.2012.02488.x","article-title":"GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces","volume":"24","author":"Galli","year":"2013","journal-title":"Clin. Oral Implants Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1172\/JCI27751","article-title":"Suppression of canonical Wnt\/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy","volume":"116","author":"Garcia-Gras","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1210\/endo.143.6.8842","article-title":"Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"143","author":"Gerhold","year":"2002","journal-title":"Endocrinology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1210\/me.2002-0020","article-title":"Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter","volume":"16","author":"Girnun","year":"2002a","journal-title":"Mol. Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.1073\/pnas.162480299","article-title":"APC-dependent suppression of colon carcinogenesis by PPARgamma","volume":"99","author":"Girnun","year":"2002b","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1478-811X-12-23","article-title":"Signaling pathway cross talk in Alzheimer's disease","volume":"12","author":"Godoy","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"B49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/107385802237176","article-title":"The Wnt signaling pathway in bipolar disorder","volume":"8","author":"Gould","year":"2002","journal-title":"Neuroscientist"},{"key":"B50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-2094-9-63","article-title":"The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function","volume":"9","author":"Gray","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/dbio.1997.8552","article-title":"Activation of the Wnt signaling pathway: a molecular mechanism for lithium action","volume":"185","author":"Hedgepeth","year":"1997","journal-title":"Dev. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0165-5728(99)00192-7","article-title":"Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase","volume":"100","author":"Heneka","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo","volume":"20","author":"Heneka","year":"2000","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/1531-8249(20010201)49:2276::AID-ANA533.0.CO;2-5","article-title":"Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease","volume":"49","author":"Heneka","year":"2001a","journal-title":"Ann. Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer's disease","volume":"184","author":"Heneka","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-2-22","article-title":"Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice","volume":"2","author":"Heneka","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jnen\/60.9.906","article-title":"Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease","volume":"60","author":"Heneka","year":"2001b","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"26039","DOI":"10.1074\/jbc.M113.461269","article-title":"The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines","volume":"288","author":"Hicks","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1460-9568.2006.05245.x","article-title":"Glycogen synthase kinase-3 inhibition is integral to long-term potentiation","volume":"25","author":"Hooper","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.13230","article-title":"Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression","volume":"135","author":"Hunsberger","year":"2015","journal-title":"J. Neurochem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexcr.2004.09.032","article-title":"Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling","volume":"304","author":"Inestrosa","year":"2005","journal-title":"Exp. Cell Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s11481-012-9417-5","article-title":"Wnt signaling: role in Alzheimer disease and schizophrenia","volume":"7","author":"Inestrosa","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bpa.12226","article-title":"Age progression of neuropathological markers in the brain of the chilean rodent octodon degus, a natural model of alzheimer's disease","volume":"25","author":"Inestrosa","year":"2015","journal-title":"Brain Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jmcb\/mjt051","article-title":"Wnt signaling in the nervous system and in Alzheimer's disease","volume":"6","author":"Inestrosa","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1073\/pnas.0405928102","article-title":"The Wnt\/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells","volume":"102","author":"Jansson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front. Biosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/iub.1097","article-title":"Peroxisome proliferator-activated receptor-gamma cofactors in neurodegeneration","volume":"64","author":"Katsouri","year":"2012","journal-title":"IUBMB Life"},{"key":"B71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1590\/S0100-879X2011007500157","article-title":"Effect of activation of canonical Wnt signaling by the Wnt-3a protein on the susceptibility of PC12 cells to oxidative and apoptotic insults","volume":"45","author":"Kawamoto","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jnr.10501","article-title":"Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation","volume":"71","author":"Kielian","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/mp.2012.163","article-title":"Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway","volume":"19","author":"Killick","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(02)02480-0","article-title":"Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2","volume":"941","author":"Kim","year":"2002","journal-title":"Brain Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1006\/bbrc.1998.9981","article-title":"Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains","volume":"254","author":"Kitamura","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.5604\/17322693.1077719","article-title":"Wnt signaling pathway\u2013its role in regulation of cell metabolism","volume":"67","author":"Kozinski","year":"2013","journal-title":"Postepy Hig. Med. Dosw."},{"key":"B77","doi-asserted-by":"publisher","first-page":"403896","DOI":"10.1155\/2008\/403896","article-title":"PPARs in Alzheimer's Disease","volume":"2008","author":"Kummer","year":"2008","journal-title":"PPAR Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","author":"Landreth","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"B80","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"429","key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00429","article-title":"Circadian rhythms, Wnt\/beta-catenin pathway and PPAR alpha\/gamma profiles in diseases with primary or secondary cardiac dysfunction","volume":"5","author":"Lecarpentier","year":"2014","journal-title":"Front. Physiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"783273","DOI":"10.1155\/2010\/783273","article-title":"PPARs, cardiovascular metabolism, and function: near- or far-from-equilibrium pathways","volume":"2010","author":"Lecarpentier","year":"2010","journal-title":"PPAR Res."},{"issue":"100","key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2016.00100","article-title":"Opposite interplay between PPAR gamma and canonical Wnt\/beta-catenin pathway in amyotrophic lateral sclerosis","volume":"7","author":"Lecarpentier","year":"2016","journal-title":"Front. Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/00005072-199911000-00006","article-title":"Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques","volume":"58","author":"Lee","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1038\/cddis.2013.180","article-title":"Glycation exacerbates the neuronal toxicity of beta-amyloid","volume":"4","author":"Li","year":"2013","journal-title":"Cell Death Dis."},{"key":"B87","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J. Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0197-4580(01)00299-8","article-title":"Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice","volume":"22","author":"Lim","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1128\/MCB.00441-06","article-title":"Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin","volume":"26","author":"Liu","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejphar.2010.03.010","article-title":"Repression of beta-catenin signaling by PPAR gamma ligands","volume":"636","author":"Lu","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"18567","DOI":"10.1073\/pnas.0509316102","article-title":"Repression of beta-catenin function in malignant cells by nonsteroidal antiinflammatory drugs","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B92","doi-asserted-by":"publisher","first-page":"21453","DOI":"10.1074\/jbc.M414390200","article-title":"Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation","volume":"280","author":"Luna-Medina","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B93","first-page":"29","article-title":"Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys","volume":"47","author":"Maeshiba","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"B94","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neuropharm.2011.08.032","article-title":"The dynamic role of beta-catenin in synaptic plasticity","volume":"62","author":"Maguschak","year":"2012a","journal-title":"Neuropharmacology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11481-012-9350-7","article-title":"A role for WNT\/beta-catenin signaling in the neural mechanisms of behavior","volume":"7","author":"Maguschak","year":"2012b","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/35077108","article-title":"LDL-receptor-related protein 6 is a receptor for Dickkopf proteins","volume":"411","author":"Mao","year":"2001","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1172\/JCI65401","article-title":"Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease","volume":"123","author":"Marcello","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B98","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"a006239","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1021\/pr400008f","article-title":"Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro","volume":"12","author":"Mendoza","year":"2013","journal-title":"J. Proteome Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/14660820310002601","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"4","author":"Miller","year":"2003","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"B102","doi-asserted-by":"publisher","first-page":"CD001447","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj20030426","article-title":"Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis","volume":"376","author":"Moldes","year":"2003","journal-title":"Biochem. J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.1071549","article-title":"The promise and perils of Wnt signaling through beta-catenin","volume":"296","author":"Moon","year":"2002","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","article-title":"The amyloid precursor protein: a biochemical enigma in brain development, function and disease","volume":"587","author":"Nalivaeva","year":"2013","journal-title":"FEBS Lett."},{"key":"B107","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1471-4159.2001.00039.x","article-title":"Survival activity of troglitazone in rat motoneurones","volume":"76","author":"Nishijima","year":"2001","journal-title":"J. Neurochem."},{"key":"B108","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/sj.cr.7290260","article-title":"Wnt signaling in disease and in development","volume":"15","author":"Nusse","year":"2005","journal-title":"Cell Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.arr.2013.03.006","article-title":"Wnt signaling: role in LTP, neural networks and memory","volume":"12","author":"Oliva","year":"2013a","journal-title":"Ageing Res. Rev."},{"issue":"224","key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00224","article-title":"Wnts in adult brain: from synaptic plasticity to cognitive deficiencies","volume":"7","author":"Oliva","year":"2013b","journal-title":"Front. Cell. Neurosci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","article-title":"Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice","volume":"199","author":"Pedersen","year":"2006","journal-title":"Exp. Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"B115","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR(gamma) and glucose homeostasis","volume":"22","author":"Picard","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"B116","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/00023210-200822090-00004","article-title":"Riluzole in the treatment of mood and anxiety disorders","volume":"22","author":"Pittenger","year":"2008","journal-title":"CNS Drugs"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI20864","article-title":"A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model","volume":"113","author":"Postina","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B118","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev.genet.32.1.461","article-title":"Alzheimer's disease: genetic studies and transgenic models","volume":"32","author":"Price","year":"1998","journal-title":"Annu. Rev. Genet."},{"key":"B119","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1017\/S0033583500000615","article-title":"Biological order, structure and instabilities","volume":"4","author":"Prigogine","year":"1971","journal-title":"Q. Rev. Biophys."},{"key":"B120","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1523\/JNEUROSCI.4562-11.2012","article-title":"The secreted Wnt antagonist Dickkopf-1 is required for amyloid beta-mediated synaptic loss","volume":"32","author":"Purro","year":"2012","journal-title":"J. Neurosci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"11615","DOI":"10.1074\/jbc.M411936200","article-title":"Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway","volume":"280","author":"Quintanilla","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","article-title":"Peroxisome proliferator-activated receptor gamma in diabetes and metabolism","volume":"25","author":"Rangwala","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1471-4159.2009.06566.x","article-title":"Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease","volume":"112","author":"Rosi","year":"2010","journal-title":"J. Neurochem."},{"issue":"103","key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00103","article-title":"WNT signaling in neuronal maturation and synaptogenesis","volume":"7","author":"Rosso","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1749-6632.1996.tb34433.x","article-title":"APP gene family. Alternative splicing generates functionally related isoforms","volume":"777","author":"Sandbrink","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B127","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1523\/JNEUROSCI.23-30-09796.2003","article-title":"Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase","volume":"23","author":"Sastre","year":"2003","journal-title":"J. Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"35583","DOI":"10.1074\/jbc.M403143200","article-title":"Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway","volume":"279","author":"Sharma","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B131","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1471-4159.2010.07131.x","article-title":"Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid beta-peptide","volume":"116","author":"Shruster","year":"2011","journal-title":"J. Neurochem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","article-title":"The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway","volume":"96","author":"Shtutman","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"97","key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00097","article-title":"Canonical Wnt signaling protects hippocampal neurons from Abeta oligomers: role of non-canonical Wnt-5a\/Ca(2+) in mitochondrial dynamics","volume":"7","author":"Silva-Alvarez","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"F703","DOI":"10.1152\/ajprenal.00189.2004","article-title":"Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors","volume":"288","author":"Sinha","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"12074","DOI":"10.1073\/pnas.95.21.12074","article-title":"A role for the beta-amyloid precursor protein in memory?","volume":"95","author":"Sisodia","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B136","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0361-9230(01)00730-4","article-title":"Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"56","author":"Sly","year":"2001","journal-title":"Brain Res. Bull."},{"key":"B137","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Suh","year":"2013","journal-title":"Neuron"},{"key":"B138","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","article-title":"Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis","volume":"5","author":"Takada","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"B140","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jalz.2011.02.002","article-title":"Stopping a thief and killer: Alzheimer's disease crisis demands greater commitment to research","volume":"7","author":"Thies","year":"2011","journal-title":"Alzheimers. Dement."},{"issue":"1","key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2012.00001","article-title":"GSK-3 and Wnt signaling in neurogenesis and bipolar disorder","volume":"5","author":"Valvezan","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1523\/JNEUROSCI.0862-13.2014","article-title":"In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model","volume":"34","author":"Vargas","year":"2014","journal-title":"J. Neurosci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1084\/jem.184.4.1425","article-title":"Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease","volume":"184","author":"Vodovotz","year":"1996","journal-title":"J. Exp. Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/00207454.2013.825258","article-title":"The potential mechanisms of Abeta-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease","volume":"124","author":"Wan","year":"2014a","journal-title":"Int. J. Neurosci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"301575","DOI":"10.1155\/2014\/301575","article-title":"The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?","volume":"2014","author":"Wan","year":"2014b","journal-title":"Biomed Res. Int."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/npp.2010.245","article-title":"Huperzine A activates Wnt\/beta-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model","volume":"36","author":"Wang","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.cmet.2008.10.009","article-title":"Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1","volume":"8","author":"Wang","year":"2008","journal-title":"Cell Metab."},{"key":"B148","doi-asserted-by":"publisher","first-page":"22293","DOI":"10.1074\/jbc.M000248200","article-title":"Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity","volume":"275","author":"Watanabe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B149","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.mp.4002093","article-title":"Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation","volume":"13","author":"Wexler","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"B151","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/jnc.13260","article-title":"Is riluzole a new drug for Alzheimer's disease?","volume":"135","author":"Whitcomb","year":"2015","journal-title":"J. Neurochem."},{"key":"B152","doi-asserted-by":"publisher","first-page":"29954","DOI":"10.1074\/jbc.M304761200","article-title":"Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway","volume":"278","author":"Xiao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B153","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","article-title":"Proteolytic processing of Alzheimer's beta-amyloid precursor protein","volume":"120","author":"Zhang","year":"2012","journal-title":"J. Neurochem."},{"key":"B155","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ejps.2011.02.009","article-title":"Curcumin activates Wnt\/beta-catenin signaling pathway through inhibiting the activity of GSK-3beta in APPswe transfected SY5Y cells","volume":"42","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1128\/MCB.20.12.4238-4252.2000","article-title":"Differential mechanisms of LEF\/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin","volume":"20","author":"Zhurinsky","year":"2000","journal-title":"Mol. Cell. Biol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2016.00459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T19:27:22Z","timestamp":1568489242000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2016.00459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":156,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00459","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]}}}